Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A round was entirely funded by founding investor Apple Tree Partners. Source: BioSpace You Might Also Like <b>Synergy Radiology Associates</b> Radiologists Using Hi-Tech, 3-D Imaging For Better Prostate Cancer Diagnosis, Less Worry July 11, 2017 Cancer Biotech Novocure Scores New $150M Debt Financing February 7, 2018 5 Biotechs Releasing Highly-Anticipated Data at ASCO May 18, 2017
<b>Synergy Radiology Associates</b> Radiologists Using Hi-Tech, 3-D Imaging For Better Prostate Cancer Diagnosis, Less Worry July 11, 2017
